Evidence map›Paper›PMID 30864327›Full record

ArticlePacific Symposium on Biocomputing. Pacific Symposium on Biocomputing2019

AICM: A Genuine Framework for Correcting Inconsistency Between Large Pharmacogenomics Datasets.

Zhiyue Tom Hu, Yuting Ye, Patrick A Newbury, Haiyan Huang, Bin Chen

Abstract read
In one paragraph

Article in Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Precision Medicine: Improving health through high-resolution analysis of personal data.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhiyue Tom HuDepartment of Biostatistics, University of California, Berkeley, USA, zyhu95@berkeley.edu.
Yuting Ye
Patrick A Newbury
Haiyan Huang
Bin Chen

Funding

Integrating transcriptomic, proteomic and pharmacogenomic data to inform individualized therapy in cancersK01ES028047 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHEN, BIN · 2017 to 2020
$682k
Targeting glucose metabolism for the treatment of Hepatocellular CarcinomaR21TR001743 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHEN, BIN · 2017 to 2018
$560k
NCATS NIH HHS R21 TR001743NIEHS NIH HHS K01 ES028047
6 · The paper itself

Abstract

The inconsistency of open pharmacogenomics datasets produced by different studies limits the usage of such datasets in many tasks, such as biomarker discovery. Investigation of multiple pharmacogenomics datasets confirmed that the pairwise sensitivity data correlation between drugs, or rows, across different studies (drug-wise) is relatively low, while the pairwise sensitivity data correlation between cell-lines, or columns, across different studies (cell-wise) is considerably strong. This common interesting observation across multiple pharmacogenomics datasets suggests the existence of subtle consistency among the different studies (i.e., strong cell-wise correlation). However, significant noises are also shown (i.e., weak drug-wise correlation) and have prevented researchers from comfortably using the data directly. Motivated by this observation, we propose a novel framework for addressing the inconsistency between large-scale pharmacogenomics data sets. Our method can significantly boost the drug-wise correlation and can be easily applied to re-summarized and normalized datasets proposed by others. We also investigate our algorithm based on many different criteria to demonstrate that the corrected datasets are not only consistent, but also biologically meaningful. Eventually, we propose to extend our main algorithm into a framework, so that in the future when more datasets become publicly available, our framework can hopefully offer a "ground-truth" guidance for references.

Indexed as

AlgorithmsCell Line, TumorComputational BiologyDatabases, GeneticDatabases, PharmaceuticalDrug Resistance, NeoplasmGenetic MarkersHumansNeoplasmsPharmacogeneticsPharmacogenomic VariantsPrecision MedicineGenetic Markers

Identifiers

PMID30864327
PMCPMC6417811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.